EverGlade Helps Cirsium Secure up to $61 Million in ARPA-H Funding
EverGlade, a national consulting firm, has helped Cirsium Biosciences successfully secure up to $61 million in funding to create a rapid, safe, scalable, and low-cost plant-based manufacturing platform to drastically reduce production time and cost of viral vector-based gene therapies. How Funding Will Be Used The $61 million in ARPA-H funding will enable Cirsium Biosciences […]
EverGlade Helps Cirsium Secure up to $61 Million in ARPA-H Funding Read More »